Objectives: To document the existence of drug resistance in a tuberculosis treatment programme that adheres strictly to the DOTS principles (directly observed treatment, short course) and to determine the extent of drug resistance in a prison setting in one of the republics of the former Soviet Union.
Introduction
Tuberculosis is an increasing problem in Azerbaijan. 1 2 In prisons this problem is compounded by overcrowding, poor general health, high prevalence of risk groups, late case finding, and incomplete treatments. As a result prevalences in prisons in Azerbaijan were almost 50 times higher than the country's average and the mortality was as high as 24% in 1994. 3 The common practice of self treatment with drugs provided by family members often results in treatment at insufficient doses and with multiple interruptions. The incidence of HIV infection in the general population is low, 4 and there is no evidence that HIV plays an important part in the current epidemic of tuberculosis in prisons. Drug resistance is known to exist in the countries of the former Soviet Union, but exact data have rarely been presented. 5 6 No data are available for Azerbaijan.
The International Committee of the Red Cross has implemented a tuberculosis control programme in the Central Penitentiary Hospital in Baku, Azerbaijan, which is the country's only treatment centre for patients with tuberculosis in prison. The programme started in June 1995 and used a short course of directly observed treatment (DOTS) as recommended by the World Health Organisation 7 and the International Union Against Tuberculosis and Lung Diseases. 8 The objective of this study was to document the existence and the extent of multidrug resistance.
Subjects and methods
We analysed sputum from two groups of patients in whom Mycobacterium tuberculosis was identified. Group 1 comprised 28 patients who did not respond, either clinically or bacteriologically, after a minimum of eight weeks to the fully supervised WHO treatment regimen. Group 2 comprised 38 patients consecutively enrolled over four weeks from whom sputum was taken before the start of the treatment. The two groups were mutually exclusive. One sputum sample was taken from each patient. We supervised collection of sputum to avoid irregularities.
Treatment protocols
We included only patients whose sentence was long enough to allow a full course of treatment. Patients received the WHO recommended DOTS regimen in the recommended doses. 9 For new cases, defined as having never been treated or treated for less than a month, treatment comprised daily doses of rifampicin, isoniazid, pyrazinamide, and streptomycin for two months followed by rifampicin and isoniazid thrice weekly for four months. For failure and relapse cases initial treatment was daily doses of rifampicin, isoniazid, pyrazinamide, and ethambutol for three months plus streptomycin for the first two months followed by rifampicin, isoniazid, and ethambutol thrice weekly for five months. Failure of treatment was defined as patients who had stopped treatment after having taken drugs for at least one month. Relapse cases were patients who had previously completed a full treatment course. Medicines were bought from the International Dispensary Association in Amsterdam and imported to ensure compliance with international standards. Drug intake was directly supervised by our staff, who observed the patients swallowing the medicines. This allowed us to achieve a compliance rate of 94%.
Microbiological analyses
Microscopy-Smears were stained with the ZiehlNeelsen technique. 10 Culture-Sputum specimens were collected in the morning, stored at 4°C, and taken in batches to the laboratories for processing. 10 inoculated on to solid media, and incubated at 36°C for eight weeks in 6% carbon dioxide. In addition, 0.5 ml of the sediment was cultivated by the radiometric BACTEC 460 TB technique.
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Identification of M tuberculosis-Routine biochemical methods 10 and Accuprobe culture confirmation kits (Gen-Probe, San Diego, CA, USA) were used to identify the isolates.
Susceptibility testing-Susceptibility to first line drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) and to streptomycin was tested with the radiometric BACTEC 460 TB method (isoniazid 0.2 g/ml; rifampicin 2.0 g/ml; ethambutol 2.5 g/ml; pyrazinamide 100 g/ml; streptomycin 2 g/ml) as well as by the proportion method on solid medium. Resistance was defined according standard protocols.
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Results
M tuberculosis was isolated from all sputum specimens (n = 66). The table shows the antibiotic resistance pattern of the strains. In group 1, 25 of the strains (89%) proved to be multidrug resistant (resistant to rifampicin and isoniazid). None was fully susceptible. The strains of all new cases and 14 out of 17 failure or relapse cases (82%) were multidrug resistant.
In group 2, nine strains (24%) were multidrug resistant and only 12 (32%) were fully susceptible. Three (15%) strains in the 20 new cases and six (33%) strains in the 18 failure and relapse cases were multidrug resistant.
Discussion
Our data show that drug resistance is common in the Central Penitentiary Hospital in Baku and an important factor in non-response to treatment.
Although these data cannot be generalised because of the limited number of samples investigated, they have implications for the management of tuberculosis in prisons. Treatment practices in Azerbaijan need to be reviewed as frequent monotherapy and multiple interrupted treatment courses undoubtedly contribute to the widespread multidrug resistance problem.
Our results suggest that the new cases were not really new or that patients became infected with drug resistant strains. We used the WHO definition of new cases, and many patients had taken antituberculous drugs for up to four weeks. It may be more appropriate to restrict the definition of new cases to patients without any history of treatment for tuberculosis.
The epidemiological implications of tuberculosis in prisons in the republics of the former Soviet Union may be more serious than commonly assumed. For example, data from Mariinsk (Siberia) indicate that a third of patients with tuberculosis have been in prison. 13 A similar trend is seen in Ivanovo, Russia (A Khomenko, personal communication). These data suggest that prisoners and former prisoners may in future have an important role in the transmission of tuberculosis, particularly of multidrug resistant forms, in the community.
National tuberculosis programmes will have to take into account the problems currently existing in prisons. The extent of tuberculosis in prisons, which is much greater than in the community, is underreported. Statistics on tuberculosis in the republics of the former Soviet Union are provided by the Ministry of Health and do not include data from prisons, which are under the jurisdiction of the Ministry of Justice (or in some countries the Ministry of Interior). Organisations running tuberculosis control programmes in prisons need to determine the presence and extent of multidrug resistance before starting a project.
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Prospective, hospital based study of fever in children in the United Kingdom who had recently spent time in the tropics
John L Klein, Guy C Millman
Published data are lacking on the subject of imported infections in children. As general practitioners and paediatricians in the United Kingdom are frequently involved in the assessment of children with such infections, this lack of information may hinder optimal management. We report the results of a one year prospective, hospital based study of all children with fever admitted to our paediatric ward who had recently spent time in the tropics.
Methods, subjects, and results
From August 1996 to July 1997 all children aged 16 years and under who were admitted with a fever (oral temperature > 37.5°C) and had been in a tropical country within the previous four weeks were entered into the study; details of the few children who had a fever and had been in the tropics but were managed as outpatients were not recorded. Demographic, clinical, and laboratory features were recorded on a standard proforma. In all, 31 children (18 boys) met the entry criteria; the median age was 4 years (range 5 months to 15 years). The regions visited were south Asia (19), sub-Saharan Africa (11) , and the Caribbean (1). Twenty one children were normally resident in the United Kingdom, five in Africa, and five in south Asia; 23 were of south Asian ethnic origin, and eight were Afro-Caribbean. Of the 20 children normally resident in the United Kingdom who had visited a malarious region, only three had been fully compliant with an accepted regimen of antimalarial prophylaxis 1 ; eight had taken no prophylaxis, and the other nine were poorly compliant, especially with proguanil.
The table shows the primary diagnoses at discharge from hospital. Fourteen children had non-specific, self limiting illnesses of presumed viral origin. Of the remaining 17 children, seven had potentially fatal infections requiring rapid diagnosis and antimicrobial treatment. All three cases of falciparum malaria were acquired in sub-Saharan Africa, and the single case of vivax malaria originated from India. Ten children had notifiable infectious diseases, and there were no deaths.
Primary diagnoses at discharge in 31 children admitted to hospital with fever after arriving in United Kingdom from the tropics
No of cases
Diagnosis
Resident in UK
Not resident in UK Total
Non-specific fever 10 4 14 
